This study indicated that increasing ubiquitination of histone 2A at lysine 119 (H2AK119ub) can promote the degradation of α-synuclein-formed aggregates and have a potential therapeutic effect in PD (Srivastava et al., 2021). The gene discussed is SNCA; the disease is Parkinson disease.